Arg452 substitution of the erythroid‐specific 5‐aminolaevulinate synthase, a hot spot mutation in X‐linked sideroblastic anaemia, does not itself affect enzyme activity
- 27 October 2005
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 76 (1) , 33-41
Abstract
Mutations of the erythroid‐specific 5‐aminolaevulinate synthase (ALAS2) gene are known to be responsible for X‐linked sideroblastic anaemia (XLSA). An amino acid (AA) substitution for arginine at the 452 AA position of the ALAS2 protein is the most frequent mutation, which has been found in approximately one‐quarter of patients with XLSA. Despite its high frequency, there has been no report on the enzymatic activity of Arg452 mutant proteins. In this study, we examined enzymatic activity in vitro of two Arg452 mutants, Arg452Cys and Arg452His, which were found in two new pedigrees of XLSA. While these mutations must be responsible for the clinical phenotype of XLSA in patients, the enzymatic activity and stability of these mutant proteins studied in vitro are indistinguishable from those of the wild type protein. These findings suggest that the Arg452 mutation of the ALAS2 gene by itself does not decrease the enzymatic activity or the stability in vitro, and that there may be an additional factor(s) in the bone marrow, which ensures the full ALAS2 activity in vivo.Keywords
This publication has 28 references indexed in Scilit:
- A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemiaBlood, 2003
- Late-onset X-linked sideroblastic anemia following hemodialysisBlood, 2003
- Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutationBlood, 2002
- Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemiaJournal of Clinical Investigation, 2000
- Anatomy of hot spots in protein interfacesJournal of Molecular Biology, 1998
- Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.Journal of Clinical Investigation, 1995
- X-linked Pyridoxine-Responsive Sideroblastic Anemia Due to a Thr388-to-Ser Substitution in Erythroid 5-Aminolevulinate SynthaseNew England Journal of Medicine, 1994
- Sideroblastic Anemia Showing Unique Response to PyridoxineJournal of Pediatric Hematology/Oncology, 1991
- Sideroblastic AnaemiaEuropean Journal of Pediatrics, 1982
- Mechanism of allylisopropylacetamide-induced increase of δ-aminolevulinate synthetase in liver mitochondriaArchives of Biochemistry and Biophysics, 1969